Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, ProQR (PRQR) has a market cap of $0.13 billion USD. According to our data, ProQR is ranked No.7397 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.13 B |
-55.39%
|
| Dec 31, 2024 | $0.28 B |
33.84%
|
| Dec 29, 2023 | $0.21 B |
-46.49%
|
| Dec 30, 2022 | $0.39 B |
-53.81%
|
| Dec 31, 2021 | $0.85 B |
90.71%
|
| Dec 31, 2020 | $0.44 B |
-57.62%
|
| Dec 31, 2019 | $1.05 B |
-37.20%
|
| Dec 31, 2018 | $1.67 B |
389.30%
|
| Dec 29, 2017 | $0.34 B |
-34.18%
|
| Dec 30, 2016 | $0.52 B |
-43.55%
|
| Dec 31, 2015 | $0.92 B |
-59.94%
|
| Dec 31, 2014 | $2.30 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Ionis Pharmaceuticals
IONS
|
$4.47 B |
-0.042 B
|
USA
|
 Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
Switzerland
|
 Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.33 B |
50.456 M
|
USA
|
 bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
USA
|
 REGENXBIO
RGNX
|
$0.33 B |
-0.000 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Moderna
MRNA
|
$10.02 B |
-0.124 B
|
USA
|
 Novartis
NVS
|
$218.28 B |
1.163 B
|
Switzerland
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
| Market Cap | = | PRQR Stock Price | * | PRQR Shares Outstanding |
| = | $1.19 | * | 0.11 B | |
| = | $0.13 B |